Filing Details

Accession Number:
0001209191-17-021535
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-17 18:31:27
Reporting Period:
2017-03-15
Filing Date:
2017-03-17
Accepted Time:
2017-03-17 18:31:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591313 R John Desjarlais C/O Xencor, Inc.
111 West Lemon Avenue
Monrovia CA 91016
Sr. V.p., Research & Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-03-15 13,755 $24.47 87,771 No 4 S Direct
Common Stock Disposition 2017-03-16 95 $0.00 87,676 No 4 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 G Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.3601 to $24.5078, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  2. Includes 145 shares of Common Stock that were acquired by the Reporting Person on December 10, 2016 pursuant to the Issuer's Employee Stock Purchase Plan.